SYKNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
STRYKER CORP
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 31, 2026
$297.94+3.28 (+1.11%)
Close on Oct 19, 2026
- Market cap
- $115.00B
- P/E (TTM)
- 30.9
- Dividend yield
- –
Share price
−$76.48 (−20.43%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.EarningsEx-dividend
STRYKER CORP grew revenue 8.5% to $25.84B over the twelve months to Jun 30, 2026. Operating income rose 53.0% to $5.53B, moving the operating margin from 15.2% to 21.4%. Free cash flow was $4.70B, up 16.8% from a year earlier.
Revenue
$25.84B
+8.5% vs. a year earlier
Operating income
$5.53B
+53.0% vs. a year earlier
Free cash flow
$4.70B
+16.8% vs. a year earlier
EPS, diluted
$9.65
+27.8% vs. a year earlier
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $115.00B
- P/E ratio
- 30.9
- Price to sales
- 4.45
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- 4.09%
Fundamentals
- Revenue
- $25.84B
- Net income
- $3.73B
- EPS, diluted
- $9.65
- Free cash flow
- $4.70B
- Diluted shares
- 386M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
$25.84B+8.5% YoY
Gross profit
$16.79B+9.9% YoY
Operating income
$5.53B+53.0% YoY
Net income
$3.73B+27.8% YoY
EPS, diluted
$9.65+27.8% YoY
Free cash flow
$4.70B+16.8% YoY
Reported periodTrailing twelve months